Search
Search Funnelback University
- Refined by:
- Date: 2020
Your query has been expanded to news |u:www.enterprize.cam.ac.uk. Search for news |u:www.enterprise.cam.ac.uk instead.
61 -
80 of
388
search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Sphere Fluidics: picolitre droplet technology – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/sphere-fluidics-picolitre-droplet/23 Oct 2020: Dr Frank Craig has been recruited as CEO, and the investment from the Discovery Fund will support the new company as it searches for its first clients and seeks additional funding, -
Researchers develop new test for children with vision loss –…
https://www.enterprise.cam.ac.uk/news/researchers-develop-new-test-for-children-with-vision-loss/23 Oct 2020: 12 October 2011. Researchers develop new test for children with vision loss. -
New funding to progress medical research from lab to clinic –…
https://www.enterprise.cam.ac.uk/news/new-funding-to-progress-medical-research-from-lab-to-clinic/23 Oct 2020: 17 August 2012. New funding to progress medical research from lab to clinic. ... Share:. Cambridge has been awarded new funding to help progress University research in the life sciences from lab to clinic. -
Potential new treatment for haemophilia developed at Cambridge
https://www.enterprise.cam.ac.uk/news/potential-new-treatment-for-haemophilia-developed-at-cambridge/23 Oct 2020: 27 October 2016. Potential new treatment for haemophilia developed by Cambridge researchers. ... Share:. A new treatment that might one day help all patients with haemophilia, including those who become resistant to existing therapies, has been -
New Cambridge Enterprise office opens on Biomedical Campus –…
https://www.enterprise.cam.ac.uk/news/new-cambridge-enterprise-office-opens-on-university-biomedical-campus/27 Nov 2020: This is done through the identification and development of commercially valuable intellectual property (IP), the formation of new companies and by supporting the provision of consultancy services to industry. ... The new office on the Addenbrooke’s -
Research reveals shocking new way to create nanoporous materials –…
https://www.enterprise.cam.ac.uk/news/research-reveals-shocking-new-way-to-create-nanoporous-materials/23 Oct 2020: Share:. Scientists have developed a new method of creating nanoporous materials with potential applications in everything from water purification to chemical sensors. ... Dr Easan Sivaniah. However, new research published this week (Sunday, 27 November) -
New MS drug proves effective where others have failed – Cambridge…
https://www.enterprise.cam.ac.uk/news/new-ms-drug-proves-effective-where-others-have-failed/23 Oct 2020: The new studies, sponsored by Genzyme (a Sanofi company) and Bayer Schering Pharma, showed that alemtuzumab significantly reduces the number of attacks (or relapses) experienced by people with MS compared to ... Although other MS drugs have emerged over -
Cambridge Innovation Capital makes investment in Gyroscope…
https://www.enterprise.cam.ac.uk/news/12282/23 Oct 2020: Dr Soraya Bekkali, Chief Executive Officer of Gyroscope Therapeutics, explained “Our goal at Gyroscope is to advance new therapies for the treatment of debilitating eye diseases such as age-related macular -
Enval wins Best New Technology category at National Recycling Awards…
https://www.enterprise.cam.ac.uk/news/enval-wins-best-new-technology-category-at-national-recycling-awards/23 Oct 2020: 20 July 2011. Enval wins Best New Technology category at National Recycling Awards. ... Share:. The patented plastic-aluminium laminate material recovery technology developed by Cambridge Enterprise portfolio company Enval was named Best New Technology -
New device could make diagnosing disease as simple as breathing –…
https://www.enterprise.cam.ac.uk/news/new-device-could-make-diagnosing-disease-as-simple-as-breathing/23 Oct 2020: 25 April 2013. New device could make diagnosing disease as simple as breathing. -
First of new generation of cancer drugs granted European approval –…
https://www.enterprise.cam.ac.uk/news/first-of-new-generation-of-cancer-drugs-granted-european-approval/23 Oct 2020: 19 December 2014. First of new generation of cancer drugs granted European approval. ... Lynparza is an innovative new anti-cancer medicine that works in a different way to previously-marketed drugs. -
University of Cambridge launches new investment scheme for start-ups…
https://www.enterprise.cam.ac.uk/news/university-of-cambridge-launches-new-investment-scheme-for-start-ups/23 Oct 2020: 17 May 2012. University of Cambridge launches new investment scheme for start-ups. ... Last year, Cambridge Enterprise reviewed 54 new business ideas and made 11 investments totalling £640,000. -
New sensor could prolong the lifespan of high-temperature engines –…
https://www.enterprise.cam.ac.uk/news/new-sensor-could-prolong-the-lifespan-of-high-temperature-engines/23 Oct 2020: 19 September 2013. New sensor could prolong the lifespan of high-temperature engines. ... said Dr Michele Scervini, a postdoctoral researcher in the Department of Materials Science and Metallurgy, who developed the new thermocouple. -
Horizon Discovery establishes two new Centres of Excellence in…
https://www.enterprise.cam.ac.uk/news/horizon-discovery-establishes-two-new-centres-of-excellence-in-cambridge/23 Oct 2020: 11 March 2013. Horizon Discovery establishes two new Centres of Excellence in Cambridge. ... Horizon will also have an exclusive option to license new intellectual property developed. -
Cambridge Enterprise refreshes its Board with five new members –…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-refreshes-its-board-with-five-new-members/23 Oct 2020: The new members are: Professor Russell Cowburn, Tony Hickson, Professor Patrick Maxwell, Lesley Millar-Nicholson and Professor Anna Vignoles. ... for the commercialisation of IP from CRUK funded projects, new start-up creation, licences and corporate -
Cambridge Enterprise joins in £14m funding round for spin-out…
https://www.enterprise.cam.ac.uk/news/apcintex-series-a/23 Oct 2020: Share:. Cambridge Enterprise has joined in a £14 million Series A funding round into ApcinteX Limited, a University of Cambridge spin-out company developing a new therapy for haemophilia. ... Apcintex has developed a new treatment that seeks to turn -
Smart glass – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/smart-glass/23 Oct 2020: Professor Ulli Steiner and colleagues from the Cavendish Laboratory have developed a new coating which is both antireflective and self-cleaning. -
Designer piercings – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/designer-piercings/23 Oct 2020: of new drugs, and enabling more efficient disease diagnosis through DNA sequence detection. ... Cavendish Laboratory, who worked with the teams at UCL and Southampton to develop the new technique. -
Under pressure – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/under-pressure/23 Oct 2020: The patterned anvils technology removes many of the difficulties associated with achieving repeatable electrical measurements under high pressure. -
PhoreMost raises £2.5m to identify new targets for therapeutics –…
https://www.enterprise.cam.ac.uk/news/phoremost-raises-2-5m-to-identify-new-druggable-targets-for-therapeutics/23 Oct 2020: 8 April 2015. PhoreMost raises £2.5m to identify new targets for therapeutics. ... Dr Chris Torrance was a founder of Horizon Discovery (LSE: HZD), which completed its IPO in March 2014, raising £37.8 million of new money. .
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.